Therabron Therapeutics CG100 Trial

The CG100 product candidate is a recombinant human CC10 protein, a secretory protein that is believed to play an important protective role in the lung via maintenance of airway epithelia, delivered by intratracheal instillation in intubated neonates.  CG100 has the potential to improve long-term clinical outcomes in preterm infants and significantly reduce the economic burden beyond the infant's initial in-patient stay. 

Share This Post...

About The Author: Graham's Foundation

Comments are closed, but trackbacks and pingbacks are open.